ENO2 and early-onset autosomal dominant Alzheimer disease: Many studies have reported elevated serum NSE concentrations in a variety of conditions associated with CNS damage, such as stroke, traumatic brain injury, Alzheimer's disease, and multiple sclerosis (43–46).